This article provides a detailed analysis of the causes of prolactin hormone level changes in women and their effects on the body. It discusses the role of the pituitary gland, hormonal imbalances, stress, medications, and other factors influencing prolactin levels. Additionally, the reproductive, metabolic, and psychological disorders resulting from increased or decreased prolactin are highlighted. The findings are significant for clinical practice in maintaining female reproductive health and preventing hormonal imbalances.

Prolactin, hormonal imbalance, amenorrhea, galactorrhea, female health, pituitary gland, reproductive disorders.

Melmed S. The Pituitary. 4th Edition. Elsevier, 2017.

Molitch M.E. Prolactin and its disorders. New England Journal of Medicine. 2005; 352: 875–889.

Schlechte J.A. Clinical practice. Prolactinoma. New England Journal of Medicine. 2003; 349: 2035–2041.

Gillam M.P., Molitch M.E., Lombardi G., Colao A. Advances in the treatment of prolactinomas. Endocrine Reviews. 2006; 27(5): 485–534.

Ben-Jonathan N., LaPensee C.R., LaPensee E.W. What can we learn from rodents about prolactin in humans? Endocrine Reviews. 2008; 29: 1–41.

Colao A., et al. Management of endocrine disease: Prolactinomas in women. European Journal of Endocrinology. 2015; 172: R65–R75.

Molitch M.E. Diagnosis and treatment of pituitary adenomas: A review. JAMA. 2017; 317(5): 516–524.

Schlechte J.A., et al. Clinical manifestations of hyperprolactinemia in women. Fertility and Sterility. 2002; 77(2): 227–231.

Biller B.M.K., et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. Journal of Clinical Endocrinology & Metabolism. 2011; 96: 273–288.

Molitch M.E., Diagnosis and management of prolactinomas in nonpregnant women. Endocrinology and Metabolism Clinics of North America. 2010; 39(2): 251–274.